evidencegaps
Primary study · included by 1 review

Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma.

Yamakawa 2022 · Yamakawa Nobuhiro, Umeda Masahiro, Yoshii Yumi, et al. · Oral diseases · 2024

Included by

Two-year follow-up outcomes of neoadjuvant therapy in oral squamous cell carcinoma: an exploratory systematic review and meta-analysis.
Non-Cochrane · prognostic · 2026 · cited as Yamakawa 2022 · Reference list 25-34; Table 1; Fig 4-8

The review does not say which of its outcomes this study informs.

1 including review in total.